CMV and EBV Reactivation after Allogeneic Transplantation

被引：1
|
作者：
Butler, Andrew [1 ]
Thurston, Andrew [2 ]
机构：
[1] Canterbury Hlth Labs, Christchurch, New Zealand
[2] Christchurch Hosp, Christchurch, New Zealand
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2015年 / 21卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2014.11.381
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
334
引用
收藏
页码：S244 / S244
页数：1
相关论文
共 50 条
  • [31] Risk factors of CMV reactivation post allogeneic haematopoietic stem cell transplantation
    Jaskula, E.
    Drabczak-Skrzypek, D.
    Mlynarczewska, A.
    Sedzimirska, M.
    Bogunia-Kubik, K.
    Lange, A.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S267 - S267
  • [32] High rate of EBV reactivation following allogeneic stem cell transplantation.
    Hebart, H
    Ott, M
    Wagner, S
    Knecht, H
    MullerKarls, N
    Muller, CA
    Kanz, L
    Einsele, H
    BLOOD, 1996, 88 (10) : 1697 - 1697
  • [33] CYTOMEGALOVIRUS (CMV) REACTIVATION AND RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANT
    Ramanathan, M.
    Cerny, J.
    Shanahan, L.
    Kroll, A.
    Nath, R.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S467 - S468
  • [34] Multimodal therapy of ganciclovir- and foscarnet-resistant CMV reactivation after allogeneic hematopoietic cell transplantation
    Schneidawind, D.
    Vogel, W.
    Faul, C.
    Beck, R.
    Hamprecht, K.
    Jahn, G.
    Kanz, L.
    Bethge, W.
    ONKOLOGIE, 2012, 35 : 213 - 213
  • [35] Preemptive treatment for EBV reactivation after allogeneic HSCT: An effective strategy
    Ahmad, I.
    Nguyenvan, C.
    Bennani, J.
    Kwan, J.
    Aoun, M.
    Lewalle, P.
    Meuleman, N.
    Martiat, P.
    Bron, D.
    ACTA CLINICA BELGICA, 2007, 62 (04): : 263 - 263
  • [36] The significance of pre-transplant cytomegalovirus (CMV) serostatus for viral reactivation after allogeneic stem cell transplantation
    Petrov, Yavor
    Ganeva, Penka
    Arnaudov, Georgi
    Tonev, Ivan
    Simeonov, Stanislav
    Mincheff, Milcho
    Balatzenko, Georgui
    Alexandrova, Dora
    Jagurinoski, Milan
    Guenova, Margarita
    Spassov, Branimir
    BONE MARROW TRANSPLANTATION, 2018, 53 : 591 - 592
  • [37] Risk factors for CMV reactivation after T-cell depleted allogeneic bone marrow transplantation.
    Lin, TS
    Zahrieh, D
    Weller, E
    Alyea, ER
    Fisher, DC
    Gribben, JG
    Freedman, AS
    Schlossman, RL
    Lee, SJ
    Antin, JH
    Ritz, J
    Soiffer, RJ
    BLOOD, 2001, 98 (11) : 480A - 481A
  • [38] Pre-emptive treatment for EBV reactivation after allogeneic haematopoietic stem cells transplantation: An effective strategy
    Ahmad, I.
    Van, C. Nguyen
    Bennani, J.
    Kwan, J.
    Aoun, M.
    Lewalle, P.
    Meuleman, N.
    Martiat, P.
    Bron, D.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S161 - S161
  • [39] CMV Reactivation Monitoring and Management after Liver Transplantation.
    Fernandez, Maria G.
    Videla, Maria G.
    Gruz, Fernando M.
    Raffa, Sebastian
    Yantorno, Silvina E.
    Gondolesi, Gabriel E.
    Descalzi, Valeria I.
    LIVER TRANSPLANTATION, 2013, 19 : S223 - S223
  • [40] Risk Factors and Prognostic Scale for CMV Reactivation in CMV Seropositive Patients after Allogeneic Hematopoietic Cell Transplantation - a Single Center Cohort Study
    Ram, Ron
    Yeshurun, Moshe
    Shpilberg, Ofer
    Cohen, Lirit
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S305 - S305
12345